PD Dr. Andreas Kremer

Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Professur für Biochemie und Molekulare Pathobiologie

THE NOX1/4 INHIBITOR GKT831 ACHIEVES CLINICALLY MEANINGFUL REDUCTIONS IN LIVER STIFFNESS, ATTENUATES CHOLESTASIS, AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (2019) Huang JC, Invernizzi P, Dalekos GN, Nevens F, Van Vlierberghe H, Zigmond E, Andrade RJ, et al. Conference contribution CLINICAL AND VIROLOGICAL CHARACTERISTICS AND RETREATMENT OF HCV-INFECTED PATIENTS WITH FAILURE TO MULTIPLE SUBSEQUENT DAA THERAPIES (2019) Dietz J, Vermehren J, Peiffer KH, Wietzke-Braun P, Muellhaupt B, Schattenberg J, Antoni C, et al. Conference contribution Rare frameshift mutation in SERPINA3 contributes to generalized pustular psoriasis (2019) Hüffmeier U, Sticht H, Wenzel J, Wilsmann-Theis D, Wolff K, Löhr S, Frey B, et al. Conference contribution Bile salt subspecies activate MRGX4 expressed on sensory neurons and cause itching in humans (2019) Wolf K, Kühn H, Leibl V, Gebhardt L, Glaudo M, Reeh P, Fischer MJM, et al. Conference contribution What are new treatment concepts in systemic itch? (2019) Kremer A Journal article, Review article Treatment of Pruritus Secondary to Liver Disease (2019) Düll M, Kremer A Journal article, Review article Lysophosphatidic acid activates peripheral glial cells (2019) Gebhardt L, Robering J, Ciotu C, Wolf K, Kühn H, Kremer A, Fischer M Conference contribution Teufelskreis aus Jucken und Kratzen (2019) Kremer A Journal article OBETICHOLIC ACID TREATMENT IS ASSOCIATED WITH IMPROVED COLLAGEN MORPHOMETRY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (2019) Kremer A, Bowlus CL, Bedossa P, Pares A, Forman LM, Drenth JPH, Ryder S, et al. Conference contribution Identification of novel MRGX2-agonists triggering mast cell degranulation and potentially mediating drug-induced pruritus (2019) Kühn H, Wolf K, Boehm F, Glaudo M, Gebhardt L, Ectors P, Agelopoulos K, et al. Conference contribution